• FLCN Mutations and mRNA Rescue in BHD Syndrome

  2026-08-17

  A 2026 study identified the FLCN variants p.W376R and p.Q44* in two Chinese Birt-Hogg-Dubé families and combined segregation analysis with cellular functional testing. Exogenous FLCN mRNA restored FLCN expression and normalized mTORC1 signaling in vitro, providing an early proof of concept for mRNA replacement while remaining far from clinical therapy.

• Hsa_circ_0001944 in NiONP-Induced Fibrosis

  2026-08-16

  A 2025 Toxics study identifies hsa_circ_0001944 as a regulatory link between FXR/TLR4 signaling, ferroptosis, and nickel oxide nanoparticle-induced collagen formation in LX-2 hepatic stellate cells. Its pharmacological and genetic experiments suggest that restoring FXR activity or circRNA expression can reduce profibrotic responses, while also highlighting important limits of cell-based mechanistic models.

• Microlipophagy and Radioresistance in SCLC

  2026-08-15

  A 2026 study identifies microlipophagy-mediated lipid droplet remodeling as a metabolic adaptation associated with radioresistant small-cell lung cancer. By combining imaging, lipid measurements, autophagy inhibition, and transcriptomics, the work connects lipid storage with post-irradiation survival and highlights autophagy as a potential radiosensitization target.

• Deep Learning for iPSC Cardiomyocyte Cardiotoxicity

  2026-08-15

  Grafton and colleagues combined high-content imaging of induced pluripotent stem cell-derived cardiomyocytes with deep learning to identify cellular patterns associated with drug-induced cardiotoxicity. Their results support a scalable, target-agnostic strategy for prioritizing safety liabilities during early discovery, while also showing why image-based predictions require orthogonal electrophysiological and functional validation.

• AZD8055: Practical mTOR Inhibition Guide

  2026-08-14

  AZD8055 is an ATP-competitive mTOR inhibitor for probing mTORC1 and mTORC2 signaling in cellular, biochemical, and selected in vivo models. This dossier-based guide covers preparation, controls, readouts, and troubleshooting while defining why the compound should not be used as evidence of clinical efficacy.

• Entinostat (MS-275): HDAC1/3 Research Guide

  2026-08-14

  Entinostat, also called MS-275 and SNDX-275, is an orally available class I HDAC inhibitor with reported biochemical selectivity for HDAC1 and HDAC3 over HDAC8. Its epigenetic activity supports cancer cell proliferation inhibition studies, retinoblastoma treatment research, and translational evaluation in solid tumor clinical trials.

• FA-PEG@ZIF8@CIP for Ultrasound-Guided TNBC Therapy

  2026-08-13

  Li et al. developed FA-PEG@ZIF8@CIP, a folate-targeted, pH-responsive ZIF-8 nanoplatform that combines ciprofloxacin delivery, ultrasound imaging, sonodynamic therapy, and immune activation for triple-negative breast cancer. The study links ultrasound-enhanced reactive oxygen species generation with immunogenic cell death and stronger CD8+ T-cell responses, while also identifying important translational limitations for future validation.

• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-08-13

  Shen and colleagues identify PP2A, encoded through the catalytic-subunit gene PPH21, as a regulator of autophagy-associated biofilm formation and antifungal resistance in Candida albicans. Their mutant, pharmacologic activation, and mouse oral-infection experiments connect PP2A-dependent ATG protein phosphorylation with reduced treatment response, providing a mechanistic framework for studying biofilm persistence.

• Medroxyprogesterone Acetate: Assay Design

  2026-08-12

  Discover how Medroxyprogesterone acetate and MPA can be evaluated through receptor-aware, tissue-specific assay design. This guide connects renal, endometrial, and neurobiological models while using vitamin D/VDR research to sharpen experimental interpretation.

• CTP Quality as a Translational Lever for mRNA Therapy

  2026-08-12

  Localized p21 mRNA delivery for bladder cancer shows how site-specific administration can expand the therapeutic potential of mRNA. This article connects the study’s tumor-suppressor biology with upstream CTP quality, in vitro transcription control, LNP development, and practical translational strategy.

• PX-478 in Prenatal Hypoxia-Induced ASD-like Rats

  2026-08-11

  This 2024 rat study links HIF-1α inhibition with improved behavioral and hippocampal outcomes after prenatal hypoxia, while identifying treatment-timing-dependent safety signals. Its findings extend hypoxia signaling pathway research into neurodevelopmental models and provide a framework for evaluating HIF-1α, PTEN, and VEGF together.

• Trolox and Pancreatic Organoids: Redox-Ready Translation

  2026-08-10

  Trolox is more than a benchmark antioxidant. In pancreatic ductal organoid workflows, it can serve as a mechanistically informed perturbation and positive control for separating oxidative injury from lineage, growth, and drug-response phenotypes. This article connects Trolox chemistry with recent advances in pancreatic organoid generation, while defining practical assay parameters, translational limitations, and a roadmap for redox-aware disease modeling.

• Indometacin Sodium: From Mechanism to Translation

  2026-08-09

  Indometacin Sodium Trihydrate is more than a conventional COX inhibitor: it offers a translational platform connecting prostaglandin synthesis inhibition with pain biology, Wnt/β-catenin signaling, oligodendrocyte differentiation, reproductive research, and stromal-cell assays. This article outlines how to validate its mechanisms, design reproducible experiments, and interpret opportunities and limitations beyond a typical product page.

• Milk-Derived Vesicle Uptake in Porcine ISC Models

  2026-08-08

  This study develops region-specific porcine intestinal stem cell models to examine how milk-derived extracellular vesicles interact with physiologically organized intestinal epithelium. Its key findings show that epithelial polarity determines vesicle uptake, while milk-derived vesicles influence stemness- and differentiation-associated gene expression in colon-derived models and are internalized through an endocytosis-sensitive process.

• Bifidobacterium, FMT, and PET Imaging in Chronic HE

  2026-08-07

  This 2025 European Journal of Neuroscience study used [18F]PBR146 micro-PET/CT to compare Bifidobacterium and fecal microbiota transplantation in bile duct ligation rats with chronic hepatic encephalopathy. Although global brain tracer uptake, behavior, and measured cytokines did not differ significantly, regional imaging and microbiome profiles suggested that Bifidobacterium may attenuate neuroinflammation more effectively than FMT in this model.

456 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page